These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1962593

  • 1. Pharmacokinetics of droloxifene and its metabolites in breast cancer patients.
    Grill HJ, Pollow K.
    Am J Clin Oncol; 1991; 14 Suppl 2():S21-9. PubMed ID: 1962593
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients.
    Tanaka Y, Sekiguchi M, Sawamoto T, Hata T, Esumi Y, Sugai S, Ninomiya S.
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):47-58. PubMed ID: 7957452
    [Abstract] [Full Text] [Related]

  • 3. Droloxifene, a new antiestrogen. Hormonal influences in postmenopausal breast cancer patients.
    Kvinnsland S.
    Am J Clin Oncol; 1991; 14 Suppl 2():S46-51. PubMed ID: 1962597
    [Abstract] [Full Text] [Related]

  • 4. Preclinical data for Droloxifene.
    Hasmann M, Rattel B, Löser R.
    Cancer Lett; 1994 Sep 15; 84(2):101-16. PubMed ID: 8076367
    [Abstract] [Full Text] [Related]

  • 5. First-pass metabolism and biliary recirculation of droloxifene in the female Sprague-Dawley rat.
    Nickerson DF, Tess DA, Toler SM.
    Xenobiotica; 1997 Mar 15; 27(3):257-64. PubMed ID: 9141233
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of toremifene.
    Anttila M, Valavaara R, Kivinen S, Mäenpää J.
    J Steroid Biochem; 1990 Jun 22; 36(3):249-52. PubMed ID: 2142247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Droloxifene, a new antiestrogen: its role in metastatic breast cancer.
    Rauschning W, Pritchard KI.
    Breast Cancer Res Treat; 1994 Jun 22; 31(1):83-94. PubMed ID: 7981460
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells.
    Knabbe C, Zugmaier G, Schmahl M, Dietel M, Lippman ME, Dickson RB.
    Am J Clin Oncol; 1991 Jun 22; 14 Suppl 2():S15-20. PubMed ID: 1835818
    [Abstract] [Full Text] [Related]

  • 12. Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: preliminary results of a double-blind dose-finding phase II trial.
    Bruning PF.
    Eur J Cancer; 1992 Jun 22; 28A(8-9):1404-7. PubMed ID: 1515258
    [Abstract] [Full Text] [Related]

  • 13. European early phase II dose-finding study of droloxifene in advanced breast cancer.
    Bellmunt J, Solé L.
    Am J Clin Oncol; 1991 Jun 22; 14 Suppl 2():S36-9. PubMed ID: 1962595
    [Abstract] [Full Text] [Related]

  • 14. Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.
    Bishop J, Murray R, Webster L, Pitt P, Stokes K, Fennessy A, Olver I, Leber G.
    Cancer Chemother Pharmacol; 1992 Jun 22; 30(3):174-8. PubMed ID: 1385761
    [Abstract] [Full Text] [Related]

  • 15. Japanese early phase II study of droloxifene in the treatment of advanced breast cancer. Preliminary dose-finding study.
    Abe O.
    Am J Clin Oncol; 1991 Jun 22; 14 Suppl 2():S40-5. PubMed ID: 1962596
    [Abstract] [Full Text] [Related]

  • 16. A phase I study of toremifene.
    Tominaga T, Abe O, Izuo M, Nomura Y.
    Breast Cancer Res Treat; 1990 Aug 22; 16 Suppl():S27-9. PubMed ID: 2149281
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer.
    Wiebe VJ, Benz CC, Shemano I, Cadman TB, DeGregorio MW.
    Cancer Chemother Pharmacol; 1990 Aug 22; 25(4):247-51. PubMed ID: 2136809
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic and biologic properties of droloxifene, a new antiestrogen.
    Eppenberger U, Wosikowski K, Küng W.
    Am J Clin Oncol; 1991 Aug 22; 14 Suppl 2():S5-14. PubMed ID: 1962598
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.
    Kisanga ER, Gjerde J, Guerrieri-Gonzaga A, Pigatto F, Pesci-Feltri A, Robertson C, Serrano D, Pelosi G, Decensi A, Lien EA.
    Clin Cancer Res; 2004 Apr 01; 10(7):2336-43. PubMed ID: 15073109
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of droloxifene in patients with metastatic breast cancer.
    Buzdar AU, Kau S, Hortobagyi GN, Theriault RL, Booser D, Holmes FA, Walters R, Krakoff IH.
    Cancer Chemother Pharmacol; 1994 Apr 01; 33(4):313-6. PubMed ID: 8281625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.